OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Tim West

2 Projects | 1 Researchers | $547,482 Invested

2010

C2N Diagnostics

Tim West, PhD

Preclinical development of plasma based AD diagnostic test using a combination of antibody administration and stable isotope labeling kinetics

  • Funding Amount: $247,482
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Status: Closed

2008

C2N Diagnostics

Tim West, PhD

Validation and Optimization of an Immunoprecipitation Assay for Amyloid Beta from Human Cerebrospinal Fluid Using Novel Antibodies

  • Funding Amount: $300,000
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Status: Closed